Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This clinical trial is a single center, single dose study of the acute effects of intranasal
insulin on energy metabolism and cognitive function in patients with schizophrenia,
schizoaffective and bipolar disorders, compared and healthy controls.